Zaina Sangale

2.8k total citations
32 papers, 1.2k citations indexed

About

Zaina Sangale is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Zaina Sangale has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Zaina Sangale's work include Prostate Cancer Treatment and Research (13 papers), Cancer, Lipids, and Metabolism (9 papers) and DNA Repair Mechanisms (8 papers). Zaina Sangale is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cancer, Lipids, and Metabolism (9 papers) and DNA Repair Mechanisms (8 papers). Zaina Sangale collaborates with scholars based in United States, United Kingdom and Germany. Zaina Sangale's co-authors include Jerry S. Lanchbury, Eliso Tikishvili, Steven Stone, Julia Reid, Alexander Gutin, William Welbourn, Elisha Hughes, Leah Gerber, Adib Younus and Jimmy Park and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Zaina Sangale

31 papers receiving 1.1k citations

Peers

Zaina Sangale
Eliso Tikishvili United States
Victor Reuter United States
Georgiana Kuhlmann United States
Ali Amin‐Mansour United States
Fabian Zohren United States
Ioannis Gounaris United Kingdom
Erin Macrae United States
Tsveta Milenkova United Kingdom
María Sanchez-Ronco Spain
Heidi Steinfeldt United States
Eliso Tikishvili United States
Zaina Sangale
Citations per year, relative to Zaina Sangale Zaina Sangale (= 1×) peers Eliso Tikishvili

Countries citing papers authored by Zaina Sangale

Since Specialization
Citations

This map shows the geographic impact of Zaina Sangale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaina Sangale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaina Sangale more than expected).

Fields of papers citing papers by Zaina Sangale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaina Sangale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaina Sangale. The network helps show where Zaina Sangale may publish in the future.

Co-authorship network of co-authors of Zaina Sangale

This figure shows the co-authorship network connecting the top 25 collaborators of Zaina Sangale. A scholar is included among the top collaborators of Zaina Sangale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaina Sangale. Zaina Sangale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Léon, Priscilla, Géraldine Cancel‐Tassin, Marie Audouin, et al.. (2018). Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy. World Journal of Urology. 36(9). 1495–1500. 19 indexed citations
3.
Morgan, Todd M., Rohit Mehra, J. Stuart Wolf, et al.. (2017). A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. European Urology. 73(5). 763–769. 49 indexed citations
4.
Telli, Melinda L., Jessica A. Hellyer, William Audeh, et al.. (2017). Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer. Breast Cancer Research and Treatment. 168(3). 625–630. 78 indexed citations
5.
Lanchbury, Jerry S., Kirsten M. Timms, Euan A. Stronach, et al.. (2016). 3-biomarker HRD score versus individual biomarker (LOH, TAI, LST) scores in platinum treated serous ovarian cancer (SOC). Annals of Oncology. 27. vi34–vi34. 3 indexed citations
6.
Timms, Kirsten M., Jack Cuzick, Chris Neff, et al.. (2016). The molecular landscape of genome instability in prostate cancer (PC). Annals of Oncology. 27. vi35–vi35. 2 indexed citations
7.
Aramini, Beatrice, Christian Casali, Alessandro Stefani, et al.. (2016). Prediction of distant recurrence in resected stage I and II lung adenocarcinoma. Lung Cancer. 101. 82–87. 20 indexed citations
8.
Koch, Michael O., Hristos Z. Kaimakliotis, Liang Cheng, et al.. (2016). Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrence. Cancer Biomarkers. 17(1). 83–88. 16 indexed citations
9.
Askeland, Eric J., et al.. (2015). Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection. Cancer Biomarkers. 15(6). 861–867. 16 indexed citations
10.
11.
Timms, Kirsten M., Victor Abkevich, Elisha Hughes, et al.. (2014). Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Breast Cancer Research. 16(6). 475–475. 273 indexed citations
12.
Bishoff, Jay T., Stephen J. Freedland, Leah Gerber, et al.. (2014). Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy. The Journal of Urology. 192(2). 409–414. 143 indexed citations
13.
Wistuba, Ignacio I., Carmen Behrens, Francesca Lombardi, et al.. (2013). Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(22). 6261–6271. 84 indexed citations
14.
Cuzick, Jack, Zi Yang, Gabrielle Fisher, et al.. (2013). Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. British Journal of Cancer. 108(12). 2582–2589. 82 indexed citations
15.
Freedland, Stephen J., Leah Gerber, Julia Reid, et al.. (2013). Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 86(5). 848–853. 143 indexed citations
16.
Atreya, Chloé E., Zaina Sangale, Mary Matli, et al.. (2013). PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival. Cancer Medicine. 2(4). 496–506. 40 indexed citations
17.
Atreya, Chloé E., Zaina Sangale, Mary Matli, et al.. (2013). Abstract 1201: PTEN null expression is concordant in colorectal cancer primaries and metastases and associates with poor survival.. Cancer Research. 73(8_Supplement). 1201–1201. 1 indexed citations
18.
Timms, Kirsten M., Victor Abkevich, Chris Neff, et al.. (2013). Abstract 1763: Frequency of homologous recombination repair defects across breast cancer subtypes.. Cancer Research. 73(8_Supplement). 1763–1763. 1 indexed citations
19.
Freedland, Stephen J., Leah Gerber, Julia Reid, et al.. (2013). 2242 PROGNOSTIC UTILITY OF CCP SCORE IN MEN WITH PROSTATE CANCER AFTER PRIMARY EXTERNAL BEAM RADIATION THERAPY. The Journal of Urology. 189(4S). 1 indexed citations
20.
Sangale, Zaina, et al.. (2010). A Robust Immunohistochemical Assay for Detecting PTEN Expression in Human Tumors. Applied immunohistochemistry & molecular morphology. 19(2). 173–183. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliso Tikishvili Breakdown of academic impact, for papers by Victor Reuter Breakdown of academic impact, for papers by Georgiana Kuhlmann Breakdown of academic impact, for papers by Ali Amin‐Mansour Breakdown of academic impact, for papers by Fabian Zohren Breakdown of academic impact, for papers by Ioannis Gounaris Breakdown of academic impact, for papers by Erin Macrae Breakdown of academic impact, for papers by Tsveta Milenkova Breakdown of academic impact, for papers by María Sanchez-Ronco Breakdown of academic impact, for papers by Heidi Steinfeldt
Rankless by CCL
2026